Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cold agglutinin disease is a type of autoimmune hemolytic anemia defined by the presence of cold autoantibodies (autoantibodies which are active at temperatures below 30B0C).
Biomarker and diagnostic research for cold agglutinin disease has been reported in the published literature.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
211 publications have been identified in PubMed for cold agglutinin disease. Research spans Case Report / Case Series (41%), Review / Meta-Analysis (26%), and Clinical Trial Publication (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 87 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about cold agglutinin disease
Research summaries | 54 | 26% |
Clinical study results | 21 | 10% |
Other research | 16 | 8% |
Disease patterns and progression | 15 | 7% |
Laboratory research | 10 | 5% |
Testing and diagnosis research | 6 | 3% |
New treatment approaches | 2 | 1% |
Sau A (2026). [PMID: 41983131](https://pubmed.ncbi.nlm.nih.gov/41983131/). *Front Immunol*. [Case Report / Case Series]
Cao T (2026). [PMID: 41473878](https://pubmed.ncbi.nlm.nih.gov/41473878/). *Clin Case Rep*. [Case Report / Case Series]
Xiao Z (2026). [PMID: 41438733](https://pubmed.ncbi.nlm.nih.gov/41438733/). *Blood Vessel Thromb Hemost*. [Gene Therapy / Novel Therapeutics]
Adam Z (2026). [PMID: 42172114](https://pubmed.ncbi.nlm.nih.gov/42172114/). *Klin Onkol*. [Review / Meta-Analysis]
Becking AL (2026). [PMID: 41994904](https://pubmed.ncbi.nlm.nih.gov/41994904/). *Eur J Haematol*. [Case Report / Case Series]
Fattizzo B (2026). [PMID: 41991255](https://pubmed.ncbi.nlm.nih.gov/41991255/). *Am J Hematol*. [Epidemiology / Natural History]
Murray A (2026). [PMID: 42275479](https://pubmed.ncbi.nlm.nih.gov/42275479/). *Transfusion*. [Case Report / Case Series]
Elmezayen ZW (2026). [PMID: 41884193](https://pubmed.ncbi.nlm.nih.gov/41884193/). *Clin Med Insights Case Rep*. [Case Report / Case Series]
Zhang X (2026). [PMID: 42023210](https://pubmed.ncbi.nlm.nih.gov/42023210/). *Front Immunol*. [Case Report / Case Series]
Michel M (2026). [PMID: 42067402](https://pubmed.ncbi.nlm.nih.gov/42067402/). *Rev Med Interne*. [Review / Meta-Analysis]
AI-curated news mentioning cold agglutinin disease
Updated Sep 4, 2026
A recent publication reviews the pathophysiology and diagnosis of cold agglutinin disease, highlighting advancements in therapeutic options. This evolving landscape may impact treatment strategies for affected patients.
temperature safeguards and peri procedural strategies for stem cell collection in cold agglutinin disease a case report and literature review
A real-world study evaluates the safety and effectiveness of sutimlimab in patients with cold agglutinin disease, providing valuable insights into its clinical application. This research contributes to the understanding of treatment options for this rare condition.